(Q30425406)

21 June 2017

A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke (English)

1 reference

21 June 2017

Elisa Cuadrado-Godia

19

0 references

Marc Ribo

object named as

Marc Ribó

13

0 references

Maite Mendioroz

1 reference

ORCID Public Data File 2021

Joan Montaner

25

object named as

Joan Montaner

1 reference

21 June 2017

Alberto del Río-Espínola

1

1 reference

21 June 2017

Israel Fernández-Cadenas

2

1 reference

21 June 2017

Dolors Giralt

3

1 reference

21 June 2017

Adoracion Quiroga

4

1 reference

21 June 2017

Maria Gutiérrez-Agulló

5

1 reference

21 June 2017

Manuel Quintana

6

1 reference

21 June 2017

Patricia Fernández-Álvarez

7

1 reference

21 June 2017

Sophie Domingues-Montanari

8

1 reference

21 June 2017

Maite Mendióroz

9

1 reference

21 June 2017

Pilar Delgado

10

1 reference

21 June 2017

Natacha Turck

11

1 reference

21 June 2017

Agustin Ruíz

12

1 reference

21 June 2017

Mar Castellanos

14

1 reference

21 June 2017

Victor Obach

15

1 reference

21 June 2017

Sergi Martínez

16

1 reference

21 June 2017

Mari Mar Freijo

17

1 reference

21 June 2017

Jordi Jiménez-Conde

18

1 reference

21 June 2017

Jaume Roquer

20

1 reference

21 June 2017

Pilar Chacón

21

1 reference

21 June 2017

Joan Martí-Fábregas

22

1 reference

21 June 2017

Jean Charles Sánchez

23

1 reference

21 June 2017

GRECOS Investigators

24

1 reference

21 June 2017

language of work or name

1 reference

1 November 2012

1 reference

21 June 2017

1 reference

21 June 2017

72

1 reference

21 June 2017

5

1 reference

21 June 2017

716-729

1 reference

Tissue plasminogen activator for acute ischemic stroke

21 June 2017

1 reference

Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors

21 January 2018

1 reference

Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.

21 January 2018

1 reference

Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.

21 January 2018

1 reference

Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.

21 January 2018

1 reference

Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.

21 January 2018

1 reference

The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis

21 January 2018

1 reference

Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients.

21 January 2018

1 reference

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey

21 January 2018

1 reference

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

21 January 2018

1 reference

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement

21 January 2018

1 reference

Interaction of human tissue plasminogen activator (t-PA) with pregnancy zone protein: a comparative study with t-PA-alpha2-macroglobulin interaction

21 January 2018

1 reference

Interaction of matrix metalloproteinases-2 and -9 with pregnancy zone protein and alpha2-macroglobulin

21 January 2018

1 reference

MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.

21 January 2018

1 reference

Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release.

21 January 2018

1 reference

Cloning of the human alpha 2-macroglobulin gene and detection of mutations in two functional domains: the bait region and the thiolester site

21 January 2018

1 reference

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

21 January 2018

1 reference

Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels

21 January 2018

1 reference

Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III

21 January 2018

1 reference

Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach

21 January 2018

1 reference

The role of bradykinin in mediating ischemic brain edema in rats.

21 January 2018

1 reference

Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein

21 January 2018

1 reference

Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke.

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.23664

1 reference

21 June 2017

1 reference